The Validity and Reliability of the Indonesian Version of the Chronic Liver Disease Questionnaire (CLDQ) in Measuring Quality of Life in Patients with Liver Cirrhosis

Irsan Hasan, Robby Pratomo Putra, Evy Yunihastuti, Juferdy Kurniawan

Abstract


Background: Liver cirrhosis remains the major cause of liver-related morbidity and mortality around the world. Cirrhosis also negatively affects health-related quality of life. Quality of life evaluation in cirrhosis treatment is often overlooked, despite its importance compared to traditional outcome. One of the specific tools to measure quality of life in cirrhosis patient is the Chronic Liver Disease Questionnaire (CLDQ). Although this tool has been widely used in many countries, no studies have been conducted on its validity and reliability in the Indonesian language. This study aimed to assess the validity and reliability of the Indonesian version of CLDQ using appropriate methods. Methods: This is a cross-sectional study conducted at Hepatobiliary outpatient clinic in Dr. Cipto Mangunkusumo National General Hospital (RSCM), from April-May 2021. The CLDQ was first translated into the Indonesian language and subsequent pretest was performed on 10 people, resulting in the final Indonesian version of the CLDQ. The final version was later tested in the main study with larger number of subjects (52 people). Validity was assessed using construct and external validity tests, while reliability was tested using internal consistency and test-retest methods. Results: The Indonesian version of CLDQ had a good construct validity (r 0.613-0.917), moderate external validity (54.1%), strong correlations between CLDQ and SF-36, good internal consistency (Cronbach-Alpha ≥ 0.7), and good test-retest reliability (ICC > 0.7). Conclusion: The Indonesian version of CLDQ is valid and reliable in measuring the quality of life of liver cirrhosis patients in Indonesia.


Keywords


chronic liver disease questionnaire; liver cirrhosis; quality of life; validity; reliability

References


Paul Starr S, Raines D. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician. 2011;84(12):1353-9.

Minino AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011;59(10):1-126.

Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362.

Sepanlou SG, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-66.

Anggraini Y. Prevalensi sirosis hepatis dengan etiologi virus Hepatitis B dan atau virus Hepatitis C di Rumah Sakit Umum Daerah dr. Zainoel Abidin Banda Aceh [Internet]. 2020. [Cited January 27th 2021]. Cited from: https://etd.unsyiah.ac.id/index.php?p=show_detail&id=37888.

Goldberg E, Chopra S, Runyon B, KM R. Overview of the complications, prognosis, and management of cirrhosis [Internet]. 2013. p. 1-7. [Cited July 5th 2020]. Cited from: https://www.uptodate.com/contents/cirrhosis-in-adults-overview-of- complications-general-management-and-prognosis.

Labenz C, Toenges G, Schattenberg JM, et al. Health-related quality of life in patients with compensated and decompensated liver cirrhosis. Eur J Intern Med [Internet]. 2019;70(September):54-9. [Cited July 5th 2020]. Cited from: https://doi.org/10.1016/j.ejim.2019.09.004.

Younossi Z, Henry L. Overall health-related quality of life in patients with end-stage liver disease. Clin Liver Dis. 2015;6(1):9-14.

CDC. Health related quality of life [Internet]. 2020. [Cited July 6th 2020]. p. 2020. Cited from: https://www.cdc.gov/hrqol/index.htm.

Orr JG, Homer T, Ternent L, et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol [Internet]. 2014;61(5):1158-65. [Cited July 6th 2020]. Cited from: http://dx.doi.org/10.1016/j.jhep.2014.06.034.

PROQOLID. Chronic liver disease questionnaire (CLDQ) [Internet]. Vol. 1999, 2020. [Cited July 20th 2020]. p. 6-7. Cited from: https://eprovide.mapi- trust.org/instruments/chronic-liver-disease-questionnaire.

Nirmala M, Wahyono D, Pramantara IDP. Evaluasi kualitas hidup penderita sirosis hati di Instalasi Rawat Jalan RSUP RS dr Sardjito Yogyakarta. J Manaj dan Pelayanan Farm. 2011;1(3):199-206.

Rey I. Health-related quality of life in liver cirrhosis patients and its correlation with Child Pugh score [Internet]. Vol. 9. 2016. p. 10. [Cited July 20th 2020]. Cited from: http:// repository.usu.ac.id/bitstream/handle/123456789/70046/Fulltext.pdf?sequence=1&i sAllowed=y.

Ismaniar DS. Uji keandalan dan kesahihan European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Hepatocellular Carcinoma-18 in Indonesia [Internet]. 2016. [Cited July 20th 2020]. p. 3-4. Cited from: http://www.lib.ui.ac.id/file?/file=pdf/abstrak/id_abstrak-20433677.pdf.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186-91.

Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10(13):1954-7.

Liu Y, Zhang S, Zhao Y, et al. Development and application of the Chinese (Mainland) version of chronic liver disease questionnaire to assess the health-related quality of life (HRQoL) in patients with chronic hepatitis B. PLoS ONE. 2016.

Benjamin J, Mani K, Saraya A, Joshi YK. Translation and validation of the Hindi version of chronic liver disease questionnaire (CLDQ) for the assessment of health related quality of life in patient with chronic liver disease in India. Tropic Gastroenterol. 2016;37(2):112-22.

Chang PE, Tan HK, Lee Y, et al. Clinical validation of the chronic liver disease questionnaire for the Chinese population in Singapore. J Gastroenterol Hepatol. 2019.

Hauser W, Schnur M, Steder-Neukamm U, Muthy FA, Grandt D. Validation of the German version of the chronic liver disease questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599-606.

Pappa E, Hatzi F, Papadopoulos AA, Niakas D. Psychometrics of the Greek chronic liver disease questionnaire for measuring HRQL. Gastroenterol Res Pract. 2015.

Rucci P, Taliani G, Cirrincione L, et al. Validity and reliability of the Italian version of the chronic liver disease questionnaire (CLDQ-I) for the assessment of health-related quality of life. Digestive and Liver Disease. 2005;37:850-60.

Mahmoudi H, Jafari P, Alizadeh-Naini M, Gholami S, Malek-Hosseini SA, Ghaffaripour S. Validity and reliability of Persian version of chronic liver disease questionnaire (CLDQ). Qual Life Res. 2012;21:1479-85.

Popovic DD, Kovavevic NV, Tepavcevic DBK, et al. Validation of the chronic liver disease questionnaire in Serbian patients. W J Gastroenterol. 2013;19(30):4950-7.

Ferrer M, Cordoba J, Garin O, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transplantation. 2005;12:95-104.

Tanaka A, Kikuchi K, Miura R, et al. Validation of the Japanese version of the chronic liver disease questionnaire for the assessment of health-related quality of life in patients with chronic viral hepatitis. Hepatol Res. 2016;46:E45-E50.

De Vale MB, Josefsson A, Lindkvist B, Kalaitzakis E. Validation of the Swedish version of the chronic liver disease questionnaire. Scandinavian J Gastroenterol. 2012;47:614-5.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.